Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
NAD(+) supplementation limits triple-negative breast oncology research models [PMID: 36690678] Laboratory literature summary: NAD(+) supplementation limits triple-negative breast oncology research models metastasis via SIRT1-P66Shc signaling
This compound is part of our Research Peptides category and is supplied for use in controlled laboratory and in vitro research environments
Vukojevic et al., 2018) as well as hyperkalemia-induced hypertension (Stupnisek et al., 2015)
UK Regulatory Status and Research Compliance The AOD-9604 10mg research peptide is classified as a research chemical in the United Kingdom
There is no established standard BPC-157 dosage for gut health
